// App-Quantinova.ai

[AB0290] : CERTOLIZUMAB PEGOL EXPOSURE IN RHEUMATOID ARTHRITIS PREGNANCIES: A CASE SERIES

Researchers

Presenter

  • M. Meroni

Principal Investigators

  • C. Pizzorni

  • S. Paolino

  • D. Gerbaldo

  • C. Gustavino

  • B. Seriolo

  • M. Cutolo

Medical Centers

  • Special Surgery Department, Obstetrics ang Gynaecology Division, Genoa, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Certolizumab pegol

  • Hydroxychloroquine

  • Prostaglandin

  • Sulfasalazine

  • Methotrexate

  • HWA-486

  • Prednisone

  • Oxytocin

  • Immunol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved